Deutsche Bank Ag\ Tarsus Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 79,166 shares of TARS stock, worth $4.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,166

Previous 15,990 395.1%

Holding current value

$4.22 Million

Previous $434,000 499.77%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$21.54 - $34.6 $1.36 Million - $2.19 Million	63,176 Added 395.1%	79,166 $2.6 Million
Q2 2024 Aug 14, 2024	BUY	$25.17 - $38.73 $112,535 - $173,161	4,471 Added 38.81%	15,990 $434,000
Q1 2024 May 15, 2024	BUY	$19.61 - $39.22 $9,177 - $18,354	468 Added 4.23%	11,519 $418,000
Q4 2023 Feb 14, 2024	SELL	$12.98 - $20.73 $3,115 - $4,975	-240 Reduced 2.13%	11,051 $223,000
Q3 2023 Nov 09, 2023	BUY	$14.75 - $24.62 $29,278 - $48,870	1,985 Added 21.33%	11,291 $200,000
Q2 2023 Aug 14, 2023	SELL	$11.57 - $19.63 $25,083 - $42,557	-2,168 Reduced 18.89%	9,306 $168,000
Q1 2023 May 15, 2023	BUY	$11.92 - $16.27 $47,501 - $64,835	3,985 Added 53.21%	11,474 $144,000
Q4 2022 Feb 13, 2023	BUY	$14.12 - $18.72 $1,722 - $2,283	122 Added 1.66%	7,489 $109,000
Q3 2022 Nov 14, 2022	SELL	$14.08 - $18.5 $16,966 - $22,292	-1,205 Reduced 14.06%	7,367 $126,000
Q2 2022 Aug 11, 2022	BUY	$11.08 - $19.08 $42,613 - $73,381	3,846 Added 81.38%	8,572 $125,000
Q1 2022 May 13, 2022	SELL	$14.49 - $24.28 $13,924 - $23,333	-961 Reduced 16.9%	4,726 $79,000
Q4 2021 Feb 11, 2022	BUY	$21.21 - $29.68 $5,726 - $8,013	270 Added 4.98%	5,687 $128,000
Q3 2021 Nov 04, 2021	SELL	$21.45 - $29.22 $3,367 - $4,587	-157 Reduced 2.82%	5,417 $116,000
Q2 2021 Aug 11, 2021	BUY	$27.16 - $38.59 $44,488 - $63,210	1,638 Added 41.62%	5,574 $161,000
Q1 2021 May 13, 2021	SELL	$27.37 - $47.25 $10,345 - $17,860	-378 Reduced 8.76%	3,936 $126,000
Q4 2020 Feb 16, 2021	BUY	$19.17 - $49.62 $82,699 - $214,060	4,314 New	4,314 $178,000

Others Institutions Holding TARS

# of Institutions

170

Shares Held

43.3M

Call Options Held

484K

Put Options Held

4.1K

View Full List

About Tarsus Pharmaceuticals, Inc.

Ticker TARS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,658,500
Market Cap $1.42B
Description
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...

More about TARS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account